http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2432470-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_81daec1e6c9fcc4a8bdfabe531a6886b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4458
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4458
filingDate 2009-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_652bc5ce526465def7f90d326566d411
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bf3f47d97b14f8642e7b0ee73483884
publicationDate 2012-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2432470-A1
titleOfInvention Treatment of heart failure with normal ejection fraction
abstract The invention relates to perhexiline, or a pharmaceutically acceptable salt thereof, for use in the treatment of HfπEF, as well as to a method of treating HfnEF, which comprises administering to an animal in need thereof an effective amount of perhexiline, or a pharmaceutically acceptable salt thereof, to treat said HFnEF. The invention further relates to a treatment programme for treating HFnEF, which involves the co-use or co-administration of perhexiline with one or more other compounds that are advantageous in treating HFnEF or the symptoms thereof.
priorityDate 2009-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419482623
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127903592
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503347
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400268
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53249194
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128238201
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406483
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID586
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4746
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137542
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554740
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5202
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127774712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID40467203
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419495382
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526951
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393605
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID587
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226493638
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2157
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394200
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127697988
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10351092
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36143
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5957
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533141
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127684899
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127688846
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400026
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226487293
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457460012
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717562

Total number of triples: 51.